Cargando…

Spatial Metrics of Interaction between CD163-Positive Macrophages and Cancer Cells and Progression-Free Survival in Chemo-Treated Breast Cancer

SIMPLE SUMMARY: A majority of breast cancer deaths are caused by aggressive molecular subtypes that are at high risk of progression. Patients with high-risk breast cancer commonly receive first-line systemic chemotherapy. Chemotherapy exerts direct cytotoxic effects on proliferating cancer cells. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maisel, Brenton A., Yi, Misung, Peck, Amy R., Sun, Yunguang, Hooke, Jeffrey A., Kovatich, Albert J., Shriver, Craig D., Hu, Hai, Nevalainen, Marja T., Tanaka, Takemi, Simone, Nicole, Wang, Li Lily, Rui, Hallgeir, Chervoneva, Inna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773496/ https://www.ncbi.nlm.nih.gov/pubmed/35053472 http://dx.doi.org/10.3390/cancers14020308

Ejemplares similares

Selection of optimal quantile protein biomarkers based on cell-level immunohistochemistry data
por: Yi, Misung, et al.
Publicado: (2023)

High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer
por: Chervoneva, Inna, et al.
Publicado: (2023)

Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment
por: Yang, Ning, et al.
Publicado: (2013)

Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms
por: Peck, Amy R, et al.
Publicado: (2016)

Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression
por: Sato, Takahiro, et al.
Publicado: (2013)

Positive Association of Fibroadenomatoid Change with HER2-Negative Invasive Breast Cancer: A Co-Occurrence Study
por: Chen, Yaqin, et al.
Publicado: (2015)

PCA-PAM50 improves consistency between breast cancer intrinsic and clinical subtyping reclassifying a subset of luminal A tumors as luminal B
por: Raj-Kumar, Praveen-Kumar, et al.
Publicado: (2019)

Pathologic evaluation of tumor-associated macrophage density and vessel inflammation in invasive breast carcinomas
por: Morita, Yoshihiro, et al.
Publicado: (2017)

Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma
por: Hills, Natalie, et al.
Publicado: (2021)

Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes
por: Peck, Amy R, et al.
Publicado: (2012)

Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism
por: Goodman, C R, et al.
Publicado: (2016)

NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancers
por: Sun, Yunguang, et al.
Publicado: (2021)

Increased breast cancer mortality due to treatment delay and needle biopsy type: a retrospective analysis of SEER-medicare
por: Pathak, Rashmi, et al.
Publicado: (2023)

Functional Blockade of E-Selectin in Tumor-Associated Vessels Enhances Anti-Tumor Effect of Doxorubicin in Breast Cancer
por: Morita, Yoshihiro, et al.
Publicado: (2020)

Genomic Heterogeneity of Breast Tumor Pathogenesis
por: Ellsworth, Rachel E., et al.
Publicado: (2009)

Chemo-metric analysis of carotenoids, chlorophylls, and antioxidant activity of Trifolium hybridum
por: Zeb, Alam, et al.
Publicado: (2020)

Transmembrane 163 (TMEM163) protein effluxes zinc
por: Sanchez, Vanessa B., et al.
Publicado: (2019)

Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy
por: Chaudhary, Lubna Naaz, et al.
Publicado: (2023)

Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intra-tumoral stromagenesis
por: Cho, Christina, et al.
Publicado: (2020)

Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer.
por: Sauter, Edward R, et al.
Publicado: (2002)

Comparative analysis of differentially abundant proteins quantified by LC–MS/MS between flash frozen and laser microdissected OCT-embedded breast tumor samples
por: Sturtz, Lori A., et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy for a Cancer Diagnosis
por: McGhee-Jez, Amy E., et al.
Publicado: (2021)

T163. Submission Withdrawn
Publicado: (2018)

Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of ‘soluble CD163’ in plasma
por: Etzerodt, Anders, et al.
Publicado: (2017)

Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells
por: Gennaro, Victoria J., et al.
Publicado: (2018)

Acute SARS-CoV-2 pneumonitis with cytotoxic CD8 positive T-lymphocytes: Case report and review of the literature
por: Puzyrenko, Andrii, et al.
Publicado: (2021)

Differential Gene Expression in Primary Breast Tumors Associated with Lymph Node Metastasis
por: Ellsworth, Rachel E., et al.
Publicado: (2011)

Collagen‐Specific HSP47 (+) Myofibroblasts and CD163 (+) Macrophages Identify Profibrotic Phenotypes in Deceased Hearts With SARS‐CoV‐2 Infections
por: Puzyrenko, Andrii, et al.
Publicado: (2023)

The Role of Isothiocyanates as Cancer Chemo-Preventive, Chemo-Therapeutic and Anti-Melanoma Agents
por: Mitsiogianni, Melina, et al.
Publicado: (2019)

To Chemo or Not to Chemo… That Is the Question
por: Martin, Maria Felisa Eva B., et al.
Publicado: (2023)

Prognostic significance of CD163+ tumor-associated macrophages in colorectal cancer
por: Xue, Tao, et al.
Publicado: (2021)

163th RB Meeting
por: CERN. Geneva. Research Board
Publicado: (2003)

Relationship Between sCD163 and mCD163 and Their Implication in the Detection and Typing of Leprosy
por: Farag, Azza Gaber Antar, et al.
Publicado: (2020)

Transmembrane 163 (TMEM163) Protein: A New Member of the Zinc Efflux Transporter Family
por: Styrpejko, Daniel J., et al.
Publicado: (2021)

Editorial: Chemo-Resistance in Gastrointestinal Cancers
por: Li, Xia, et al.
Publicado: (2022)

Amplification of HER2 is a marker for global genomic instability
por: Ellsworth, Rachel E, et al.
Publicado: (2008)

Development of Dimethyl Sulfoxide Solubility Models Using 163 000 Molecules: Using a Domain Applicability Metric to Select More Reliable Predictions
por: Tetko, Igor V., et al.
Publicado: (2013)

Knowledge about the presence or absence of miRNA isoforms (isomiRs) can successfully discriminate amongst 32 TCGA cancer types
por: Telonis, Aristeidis G., et al.
Publicado: (2017)

(18)F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy
por: Simoni, Nicola, et al.
Publicado: (2020)

DNA aneuploidy and breast cancer: a meta-analysis of 141,163 cases
por: Xu, Jing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4hcbca02ntpf3o9gpsso0aepd8